Sepsis is an important, life-threatening disease whose incidence is rising. In the United States, it accounts for more than 200,000 deaths and over $16.7 billion in health care expenditures. Treatment of this lethal disorder is supportive because the underlying pathophysiology is poorly understood. The normal natural history of sepsis has been well-defined. It presents with a hypermetabolic, hyperinflammatory state. Fortunately, clinicians have become quite adept at managing this phase of the syndrome so death early on is rare. Over time, the patient's condition evolves to a state of reduced organ function, the Multiple Organ Dysfunction Syndrome (MODS). Most sepsis-associated deaths occur in patients with MODS and often reflect decreased immune system function. Immune dysfunction may occur because immune cells cease to function or change their pattern of function. If immune dysfunction represents one component of MODS, it is logical to assume that similar changes - either decreased or altered function - occur in other organs. In our studies, we examine this possibility in liver cells, or hepatocytes. Using a mouse model of sepsis, we have shown that hepatocyte function changes dramatically over time and in the face of severe, as opposed to mild, sepsis. The nature of this change is unknown and therefore therapeutic approaches are lacking. We propose that the change results from an alteration in the pathways by which hepatocytes respond to signals that arise outside an individual cell. These signals may be initiated by others liver cells, cells in the blood stream or molecules dissolved in the blood. The underlying defect may result from a failure of cells to generate energy for biochemical reactions. We will examine the response to a single mediator, EL-6, and determined if the IL-6 signaling pathway is impaired in sepsis. We also will investigate the effects of sepsis on a key enzyme that is responsible for generating energy in liver cells. Finally, we will determine if EL-6 administration can reverse the defect. These studies should provide important information regarding septic biology and suggest novel therapeutic approaches. ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM059930-07
Application #
7210728
Study Section
Special Emphasis Panel (ZRG1-SBIB-E (02))
Program Officer
Dunsmore, Sarah
Project Start
2000-06-01
Project End
2010-03-31
Budget Start
2007-04-01
Budget End
2008-03-31
Support Year
7
Fiscal Year
2007
Total Cost
$306,438
Indirect Cost
Name
University of Pennsylvania
Department
Anesthesiology
Type
Schools of Medicine
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Deutschman, Clifford S (2018) Translational Research: The Model Matters. Crit Care Med 46:835-837
Deutschman, Clifford S; Raj, Nichelle R; McGuire, Erin O et al. (2013) Orexinergic activity modulates altered vital signs and pituitary hormone secretion in experimental sepsis. Crit Care Med 41:e368-75
Abcejo, Arnoley; Andrejko, Kenneth M; Ochroch, E Andrew et al. (2011) Impaired hepatocellular regeneration in murine sepsis is dependent on regulatory protein levels. Shock 36:471-7
Kilpatrick, Laurie E; Standage, Stephen W; Li, Haiying et al. (2011) Protection against sepsis-induced lung injury by selective inhibition of protein kinase C-? (?-PKC). J Leukoc Biol 89:3-10
Aschkenasy, Gabriella; Bromberg, Zohar; Raj, Nichelle et al. (2011) Enhanced Hsp70 expression protects against acute lung injury by modulating apoptotic pathways. PLoS One 6:e26956
Ruggieri, Albert J; Levy, Richard J; Deutschman, Clifford S (2010) Mitochondrial dysfunction and resuscitation in sepsis. Crit Care Clin 26:567-75, x-xi
Verma, Richa; Huang, Zhishan; Deutschman, Clifford S et al. (2009) Caffeine restores myocardial cytochrome oxidase activity and improves cardiac function during sepsis. Crit Care Med 37:1397-402
Abcejo, Arnoley S; Andrejko, Kenneth M; Raj, Nichelle R et al. (2009) Failed interleukin-6 signal transduction in murine sepsis: attenuation of hepatic glycoprotein 130 phosphorylation. Crit Care Med 37:1729-34
Piel, David A; Deutschman, Clifford S; Levy, Richard J (2008) Exogenous cytochrome C restores myocardial cytochrome oxidase activity into the late phase of sepsis. Shock 29:612-6
Bromberg, Zohar; Raj, Nichelle; Goloubinoff, Pierre et al. (2008) Enhanced expression of 70-kilodalton heat shock protein limits cell division in a sepsis-induced model of acute respiratory distress syndrome. Crit Care Med 36:246-55

Showing the most recent 10 out of 20 publications